5 terminated. 5 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Terminated 5 |
| Phase 2 | 1 | Terminated 1 |
Follow Systemic Vasculitis: new trials by email Literature Review of Systemic Vasculitis trials Research Report on Systemic Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study Comparing the New Immunosuppressive Drug Gusperimus With the Conventional Treatment in Wegener's Granulomatosis Gusperimus + glucocorticoids, cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids - Wegeners Granulomatosis | Phase 3 | Terminated | Nordic Pharma SAS | 4 | 2011-11-01 | 2015-05-29 |
| GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseases depot leuprolide acetate 3.75 mg, Placebo - Lupus Erythematosus, Systemic, Systemic Vasculitis | Phase 3 | Terminated | Joseph Mccune | 14 | 2011-05-01 | 2017-06-27 |
| IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic Vasculitis Cyclophosphamide, Mycophenolate mofetil, Azathioprine - ANCA Associated Systemic Vasculitis Including Wegener's, Granulomatosis and Microscopic Polyangiitis and | Phase 3 | Terminated | Assistance Publique - Hôpitaux de Paris | 160 | 2003-05-01 | 2006-04-10 |
| Intravenous Immunoglobulin After Relapse in Vasculitis Intravenous immunoglobulins (human immunoglobulins G) - ANCA + Vasculitides Relapsing Either Under Corticosteroid, and Immunosuppressant Therapies or After One Year | Phase 3 | Terminated | Assistance Publique - Hôpitaux de Paris | 40 | 2001-03-01 | 2006-05-22 |
| Plasma Exchange for Renal Vasculitis Plasma exchange, Intravenous methyl prednisolone, Methyl prednisolone - Wegener's Granulomatosis, Microscopic Polyangiitis | Phase 2 / Phase 3 | Terminated | Cambridge University Hospitals NHS Foundation Trust | 150 | 1995-03-01 | 2011-08-03 |
Granulomatosis with Polyangiitis (2) · Microscopic Polyangiitis (2) · Recurrence (2) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Lupus Erythematosus, Systemic (1) · Vasculitis (1)
Autoimmune Diseases (5) · Cardiovascular Diseases (5) · Immune System Diseases (5) · Skin and Connective Tissue Diseases (5) · Vascular Diseases (5) · Skin Diseases (4) · Skin Diseases, Vascular (4) · Vasculitis (4) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (3) · Brain Diseases (2) · Central Nervous System Diseases (2) · Cerebral Small Vessel Diseases (2) · Cerebrovascular Disorders (2) · Disease Attributes (2)
Azathioprine (2) · Cyclophosphamide (1) · Glucocorticoids (1) · Immunoglobulins, Intravenous (1) · Leuprolide (1) · Methotrexate (1) · Methylprednisolone (1) · Mycophenolic Acid (1) · Plasma Exchange (1) · Prednisone (1) · gusperimus (1)
Assistance Publique - Hôpitaux de Paris (2) · Cambridge University Hospitals NHS Foundation Trust (1) · Joseph Mccune (1) · Nordic Pharma SAS (1)
France (2) · United Kingdom (2) · Czechia (1) · United States (1)
David Jayne, MD (1) · Niels Rasmussen, MD (1) · William J McCune, M.D. (1)
PMID 18163506, PMID 21060104, PMID 23615499, PMID 28592297
R01HD066139 (1)